ArticleESMO open2023

Comparison of clinical safety between standard versus extended interval dosing of immune checkpoint inhibitors: a real-world retrospective cohort study.

J Colard-Thomas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.